Benchmark 2022-B36 Mortgage Trust has recently filed an ABS-EE report, providing insights into its commercial mortgage assets. This filing, dated October 27, 2026, is significant as it highlights the performance metrics of various commercial loans, showcasing the trust's ongoing operations in the asset-backed securities market.
Benchmark 2022-B36 Mortgage Trust, classified under the SIC code 6189 for Asset-Backed Securities, operates primarily in the realm of securitizing commercial mortgages. The trust is a part of a larger trend in the financial industry, where asset-backed securities continue to play a critical role in financing and investment strategies.
Background
Benchmark 2022-B36 Mortgage Trust, identified by its CIK number 0001927678, is incorporated in Delaware and operates as an entity focused on asset-backed securities. The trust has been active in the market, with its recent filings including a 10-D and an ABS-EE on the same date, October 27, 2026, as well as previous filings dating back to September.
What the Filing Says
The latest filing provides detailed information about the underlying assets, specifically commercial mortgages. The report covers the period starting September 12, 2026, and ending October 13, 2026. It includes information about the loan amounts, interest rates, and property details, emphasizing the trust's operational metrics.
Impact
This filing may affect various stakeholders, including investors and financial institutions involved in asset-backed securities. Notably, J.P. Morgan Chase Commercial Mortgage Securities Corp. and Citi Real Estate Funding Inc. are mentioned as key players in the securitization process, highlighting the competitive landscape in the asset-backed securities market.
What's Next
The filing does not specify what happens next, leaving stakeholders to anticipate further updates or filings that may provide additional insights into the trust's performance and market strategy.
Read Next
UBS AG reports third quarter financial results for 2026
Polar Power offers 8.6 million shares in prospectus update
Rapport Therapeutics announces $175M stock offering, $150M notes
UBS Group AG reports third-quarter results, sees decline
JPMorgan Chase Financial Co. files new market-linked securities
JPMorgan Chase announces new market-linked securities offering






